Seth Harmon - Nov 10, 2023 Form 4 Insider Report for Viridian Therapeutics, Inc.\DE (VRDN)

Role
Senior Vice President of Finance
Signature
/s/ Seth Harmon
Stock symbol
VRDN
Transactions as of
Nov 10, 2023
Transactions value $
$0
Form type
4
Date filed
11/13/2023, 05:17 PM
Previous filing
Sep 19, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction VRDN Stock Option (Right to Buy) Award $0 +270K $0.00 270K Nov 10, 2023 Common Stock 270K $13.76 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vests in equal monthly installments through November 10, 2027, subject to the Reporting Person's continued service to Issuer through each vesting date.

Remarks:

Senior Vice President of Finance